On the Record · Celgene
Celgene competitors, on the record
The companies Celgene itself names as competitors in its annual reports, 2016 to 2018, each with the sentence it appears in and the filing it came from.
Who Celgene names
| Company | Named in |
|---|---|
| AbbVie | 2018 |
In its own words
AbbVie
Word for word“Our present and potential competitors include major pharmaceutical and biotechnology companies, as well as specialty pharmaceutical firms, including, but not limited to: • Hematology and Oncology: AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eisai, Gilead, Johnson & Johnson, Merck, Novartis, Roche/Genentech, Sanofi and Takeda; and • Inflammation and Immunology: AbbVie, Amgen, Biogen, Eisai, Eli Lilly, Johnson & Johnson, Merck, Novartis, Pfizer and UCB S.A.” 10-K for 2018
Read from Celgene’s annual reports (10-K for 2018, 10-K for 2017, 10-K for 2016) and the financial data it files with the SEC, as of 2019-02-26. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.